SCHEMBL2885965

SCHEMBL2885965

CCOC(=O)c1ncc2c(ccn2C(C)c2ccccc2)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
GABRA1 P14867 2/20 0.53
GABRB2 P47870 2/20 0.53
CYP11B1 P15538 2/20 0.53
CYP11B2 P19099 2/20 0.53
LMNA P02545 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
ABCB11 O95342 1/20 0.53
GABRA2 P47869 1/20 0.53
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
ELANE P08246 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
EGLN1 Q9GZT9 4/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2885966 1.00 CYP1A2 (0.53) CYP1A2CYP3A4GABRA1GABRB2CYP11B1
SCHEMBL2885191 1.00 CYP1A2 (0.53) CYP1A2CYP3A4GABRA1GABRB2CYP11B1
SCHEMBL2881651 0.80 NPC1 (0.48) GABRB2GABRA2ELANEKDM4EALDH1A1
SCHEMBL2884901 0.80 EGLN1 (0.55) EGLN1
SCHEMBL2887838 0.80 EGLN1 (0.55) EGLN1
SCHEMBL2884510 0.78 EGLN1 (0.54) EGLN1
SCHEMBL2885193 0.76 MAPT (0.46) ELANEKDM4EALDH1A1EGLN1NPC1
SCHEMBL2886580 0.76 GABRA1 (0.45) CYP1A2CYP3A4GABRA1GABRB2CYP11B1
SCHEMBL2884388 0.76 GABRA1 (0.45) CYP1A2CYP3A4GABRA1GABRB2CYP11B1
SCHEMBL2884384 0.76 GABRA1 (0.45) CYP1A2CYP3A4GABRA1GABRB2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124489-B1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2020-07-15 EP disclosed
EP-3124489-A1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS Fibrogen, Inc. (US) 2017-02-01 EP disclosed
EP-2016078-B1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2016-06-15 EP disclosed
US-7696223-B2 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) FIBROGEN, INC. (US) 2010-04-13 US disclosed
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF HIF1AN, HIF1A, EGLN2 CYP1A2 3345/4885CYP3A4 2477/4885GABRA1 2510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.